Actively Recruiting
Evaluation of Efficacy of Anthelios Sunscreen on Face Versus Usual Routine on Signs of Aging
Led by Cosmetique Active International · Updated on 2024-11-20
260
Participants Needed
1
Research Sites
69 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This experimental, randomized study aims at evaluating the preventative effect of a Sun Protection Factor (SPF) 50+ sunscreen (Anthelios UVMUNE 400 Fluid SPF 50+) with high Ultraviolet A (UVA) protection on clinical signs of skin aging.
CONDITIONS
Official Title
Evaluation of Efficacy of Anthelios Sunscreen on Face Versus Usual Routine on Signs of Aging
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Subjects with signs of photo aging (Global score of at least 14)
- All skin types
- Age between 30 and 60 years
You will not qualify if you...
- History of significant dermatological or ophthalmological diseases or medical conditions affecting skin appearance or response (e.g., diabetes) that may interfere with product application or evaluation
- Pregnant or breastfeeding women
- Known allergy to cosmetic products or any ingredient of the sunscreen product
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
CIDP
Rio de Janeiro, Brazil, 20231-048
Actively Recruiting
Research Team
R
Renato Moura
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here